# Effect of Single-Dose Imipramine on Anal Sphincter Tone in Healthy Women: A Randomized, Placebo-Controlled Study Using Anal Acoustic Reflectometry

**Authors:** Thea Christoffersen, Jonatan Kornholt, Troels Riis, David P. Sonne, Niels Klarskov

PMC · DOI: 10.1007/s00192-024-05890-5 · International Urogynecology Journal · 2024-08-21

## TL;DR

This study shows that a single dose of imipramine increases anal sphincter tone in healthy women, as measured by a new technique called anal acoustic reflectometry.

## Contribution

The study is the first to demonstrate imipramine's effect on anal sphincter tone using anal acoustic reflectometry in a placebo-controlled trial.

## Key findings

- Imipramine increased anal opening pressure by 15.2 cmH2O in the resting state compared to placebo.
- During squeezing, imipramine increased anal opening pressure by 15.1 cmH2O compared to placebo.
- Anal acoustic reflectometry proved effective for assessing drug effects on anal sphincter function.

## Abstract

Despite the high prevalence of fecal incontinence, existing treatment options may be inadequate. Drugs that enhance the tone of the anal sphincter complex could potentially be an effective pharmacological approach. This study investigated the effect of the tricyclic antidepressant imipramine on anal sphincter tone in healthy women, employing anal acoustic reflectometry as the evaluating method.

In a double-blind, randomized, placebo-controlled crossover study, 16 healthy female volunteers were randomized to one of two treatment sequences. The participants attended two study visits separated by at least 7 days’ washout. At each visit, they received a single dose of 50 mg imipramine or matching placebo, in alternating order. We assessed the anal opening pressure under the resting state and during voluntary squeezing of the pelvic floor. Measurements were performed pre-dose and 1 h after drug administration, corresponding to the estimated time of peak plasma concentration of imipramine.

All participants completed the study. In total, 44% of the participants reported at least one adverse effect, primarily anticholinergic. Compared with placebo, imipramine increased anal opening pressure by 15.2 cmH2O (95% confidence interval [CI] 2.0–28.2 cmH2O, p = 0.03) in the resting state and 15.1 (95% CI 4.2–26.0 cmH2O, p = 0.01) cmH2O during squeezing.

The findings indicate that imipramine increases anal sphincter tone in healthy women. However, further research is required to evaluate its clinical impact on individuals with fecal incontinence. This research also demonstrates the effectiveness of using anal acoustic reflectometry for assessing pharmacological effects on anal sphincter function.

## Linked entities

- **Chemicals:** imipramine (PubChem CID 3696)

## Full-text entities

- **Diseases:** fecal incontinence (MESH:D005242)
- **Chemicals:** Imipramine (MESH:D007099)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11420375/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11420375/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11420375/full.md

---
Source: https://tomesphere.com/paper/PMC11420375